Latest Healthcare It News

Page 1 of 142
Resonance Health delivered a $1.5 million profit and positive operating cash flow in every quarter of FY26, while raising $6 million to accelerate three growth programmes. The challenge is replacing a MASH trial that generated 48% of last year’s revenue.
Ada Torres
Ada Torres
19 Nov 2026
Oceania Healthcare has moved Cash Flow from Existing Operations into a NZ$0.4 million inflow, while underlying EBITDA rose 18% to NZ$49.0 million in the six months to 30 September 2026. The turnaround came with stronger resales, higher care occupancy and lower costs, although the company remained loss-making on a statutory basis and withheld its interim dividend.
Victor Sage
Victor Sage
19 Nov 2026
Expeditors has outlined a long-term growth model targeting 5% to 7% annual revenue growth and 12% to 15% EPS growth. The logistics group also issued Q4 and full-year 2026 EPS guidance while flagging artificial intelligence, automation and potential acquisitions as part of its growth plan.
Maxwell Dee
Maxwell Dee
19 Nov 2026
ParagonCare says it achieved its FY26 guidance and lifted underlying EBITDA 16.5% to $97.2 million, despite a statutory earnings hit from the Infinity Pharmacy Group bad debt. The healthcare distributor is now turning to Asian expansion, operational efficiency and an active share buyback in FY27.
Ada Torres
Ada Torres
18 Nov 2026
Vital Infrastructure will sell about 95.9 million Vital Healthcare units for net proceeds of C$123.7 million, reducing its holding to approximately 11.9%. The proceeds are earmarked for debt repayment and North American healthcare property acquisitions.
Eva Park
Eva Park
18 Nov 2026
Infratil lifted FY27 operating EBITDAF guidance after a 28% first-half increase, led by data centres, renewables and One NZ. But the growth came with a NZ$247.8 million loss attributable to shareholders, a NZ$256 million incentive-fee provision and a sharp increase in capital spending.
Victor Sage
Victor Sage
18 Nov 2026
Viatris has completed its US$1.69 billion cash acquisition of Pacira BioSciences, taking full ownership of the non-opioid pain management company. Pacira is expected to contribute US$90 million to US$100 million in revenue over the remainder of 2026.
Victor Sage
Victor Sage
18 Nov 2026
Regis Healthcare delivered higher revenue, earnings and cash generation in FY26, but its new CEO is confronting a sharp funding gap across the aged care sector. The company plans to offset weaker AN-ACC support through pricing, cost reductions and further expansion.
Ada Torres
Ada Torres
17 Nov 2026
Marlin Global outperformed its benchmark in October as financial, healthcare and consumer holdings offset sharp falls in Alphabet and Meta. The Fisher Funds-managed portfolio recorded a 0.1% gross return while adjusted NAV slipped 0.1%.
Claire Turing
Claire Turing
17 Nov 2026
Barramundi’s portfolio outperformed its benchmark in October, but two holdings each fell 46% after company-specific setbacks. The NZX-listed investment company also added Wesfarmers as its one new position during the month.
Victor Sage
Victor Sage
17 Nov 2026
Moderna’s chief legal officer will retire in March under an agreement that provides US$1.63 million in fixed severance and up to US$8 million linked to litigation outcomes. The package also preserves her salary, benefits and equity vesting through her departure date.
Ada Torres
Ada Torres
14 Nov 2026
Mach7 Technologies has signed Temple Health to a five-year licence for its eUnity Viewer and Vendor Neutral Archive, with Year 1 annual recurring revenue expected to reach A$0.5 million. The revenue will depend on go-live and first productive use, forecast within six to 12 months.
Victor Sage
Victor Sage
13 Nov 2026

Browse the archive

Full archive